Kronox Lab Sciences IPO Logo

Kronox Lab Sciences IPO

Live Updates, GMP, Subscription Data, and Financial Details

IPO Overview

Listed
Dates Jun 03 to Jun 05 2024
Price Band ₹129 - 136
Current GMP ₹164.95(21.29%)
Subscription 117.25 times

IPO Details

IPO Date
June 3, 2024 to June 5, 2024
Listing Date
Monday, June 10, 2024
Face Value
₹10 per share
Price Band
₹129 to ₹136 per share
Lot Size
110 Shares
Total Issue Size
9,570,000 shares (aggregating up to ₹130.15 Cr)
Offer for Sale
9,570,000 shares of ₹10 (aggregating up to ₹130.15 Cr)
Issue Type
Book Built Issue IPO
Listing At
BSE, NSE
Share holding pre issue
37,104,000
Share holding post issue
37,104,000

IPO Subscription Details

Qualified Institutions
89.03
Non-Institutional Buyers
301.92
bNII (bids above ₹10L)
322.26
sNII (bids below ₹10L)
261.22
Retail Investors
54.24
Total **
117.25

Day Wise Sub

DayDay 1 Jun 3, 2024
QIB0.44
NII20.11
Retail13.35
Total7.91
DayDay 2 Jun 4, 2024
QIB3.39
NII53.10
Retail24.89
Total24.80
DayDay 3 Jun 5, 2024
QIB89.03
NII301.92
Retail54.24
Total117.25

Day Wise GMP

Date10-06-2024
Price136.00
GMP28(20.59%)
Estimate List Price164
Date09-06-2024
Price136.00
GMP28(20.59%)
Estimate List Price164
Date08-06-2024
Price136.00
GMP30(22.06%)
Estimate List Price166
Date07-06-2024
Price136.00
GMP33(24.26%)
Estimate List Price169
Date06-06-2024
Price136.00
GMP30(22.06%)
Estimate List Price166
Date05-06-2024
Price136.00
GMP40(29.41%)
Estimate List Price176
Date04-06-2024
Price136.00
GMP48(35.29%)
Estimate List Price184
Date03-06-2024
Price136.00
GMP81(59.56%)
Estimate List Price217
Date02-06-2024
Price136.00
GMP82(60.29%)
Estimate List Price218
Date01-06-2024
Price136.00
GMP82(60.29%)
Estimate List Price218
Date31-05-2024
Price136.00
GMP82(60.29%)
Estimate List Price218
Date30-05-2024
Price136.00
GMP82(60.29%)
Estimate List Price218
Date29-05-2024
Price136.00
GMP80(58.82%)
Estimate List Price216

IPO Important Dates

IPO Open Date
Monday, June 3, 2024
IPO Close Date
Wednesday, June 5, 2024
Basis of Allotment
Thursday, June 6, 2024
Initiation of Refunds
Friday, June 7, 2024
Credit of Shares to Demat
Friday, June 7, 2024
Listing Date
Monday, June 10, 2024
Cut-off time for UPI mandate confirmation
5 PM on June 5, 2024

IPO Lot Size

ApplicationRetail (Min)
Lots1
Shares110
Amount₹14,960
ApplicationRetail (Max)
Lots13
Shares1430
Amount₹194,480
ApplicationS-HNI (Min)
Lots14
Shares1,540
Amount₹209,440
ApplicationS-HNI (Max)
Lots66
Shares7,260
Amount₹987,360
ApplicationB-HNI (Min)
Lots67
Shares7,370
Amount₹1,002,320

Financial Information

Period EndedPeriod Ended
31 Dec 202331 Dec 2023
31 Mar 202331 Mar 2023
31 Mar 202231 Mar 2022
Period EndedAssets
31 Dec 202366.96
31 Mar 202354.03
31 Mar 202256.79
Period EndedRevenue
31 Dec 202368.44
31 Mar 202397.50
31 Mar 202283.34
Period EndedProfit After Tax
31 Dec 202315.47
31 Mar 202316.62
31 Mar 202213.63
Period EndedNet Worth
31 Dec 202360.28
31 Mar 202344.68
31 Mar 202240.35
Period EndedReserves and Surplus
31 Dec 202315.56
31 Mar 20237.58
31 Mar 202240.11
Period EndedTotal Borrowing
31 Dec 2023
31 Mar 2023
31 Mar 20220.64

Key Performance Indicator

ROE
25.66%
ROCE
33.15%
RoNW
25.66%
P/BV
8.37
PAT Margin (%)
22.6
EPS (Rs)
4.48

IPO Reservation

Investor CategoryAnchor Investor Shares Offered
Shares Offered-
Maximum AllotteesNA
Investor CategoryQIB Shares Offered
Shares Offered1,914,000 (28.57%)
Maximum AllotteesNA
Investor CategoryNII (HNI) Shares Offered
Shares Offered1,435,500 (21.43%)
Maximum Allottees
Investor CategorybNII > ₹10L
Shares Offered957,000 (14.29%)
Maximum Allottees621
Investor CategorysNII < ₹10L
Shares Offered478,500 (7.14%)
Maximum Allottees310
Investor CategoryRetail Shares Offered
Shares Offered3,349,500 (50.00%)
Maximum Allottees30,450
Investor CategoryTotal Shares Offered
Shares Offered6,699,000 (100%)
Maximum Allottees

Information about company

Incorporated in 2008, Kronox Lab Sciences Limited is a manufacturer of high-purity speciality fine chemicals for diverse end-user industries. The company's High Purity Specialty Fine Chemicals are used in various applications such as manufacturing APIs, pharmaceutical formulations, scientific research, nutraceuticals, biotech applications, agrochemical formulations, personal care products, metal refineries, and animal health products. The company offers a wide range of over 185 products, including phosphate, sulphate, acetate, chloride, citrate, nitrates, nitrites, carbonate, EDTA derivatives, hydroxide, succinate, gluconate, and others. These products are supplied to customers in India and more than 20 countries worldwide. The company exports its products to countries such as United States, Argentina, Mexico, Australia, Egypt, Spain, Turkey, United Kingdom, Belgium, United Arab Emirates, China, among others. The company has three manufacturing facilities in Vadodara, Gujarat, close to the seaports of Mundra, Kandla, Hazira, and Nhava Sheva. The facilities cover 17,454 sq. m. and have an installed capacity of 7,242 TPA as of December 31, 2023. Unit I/II holds FSSC 22000 (Version 5), ISO 9001:2015, ISO 14001:2015, and ISO 45001:2018 certifications. Additionally, some products manufactured at Unit I have obtained Kosher, Halal, GMP, and GLP certifications. As of December 31, 2023, the company is conducting research and development on 122 products. The company has served over 592 customers in the past three years. By December 31, 2023, 141 customers of the total, placed repeat orders. As of December 31, 2023, the company employees 212 people at various levels.

Objectives of IPO

The Objects of the Offer are to: Carry out the Offer for Sale of up to 95,70,000 Equity Shares by the Promoter Selling Shareholders; and Achieve the benefits of listing the Equity Shares on the Stock Exchanges. Further, the Company expects that the proposed listing of the Equity Shares will enhance the visibility and brand image, provide liquidity to its existing Shareholders, and provide a public market for Equity Shares in India.

Disclaimer

All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions. We are not a SEBI Registered analyst. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on Information published on this application. No financial information whatsoever published anywhere, within this application, should be considered as advice to buy or sell securities or invest in IPOs, or as a guide to doing so in any way whatsoever Please read all Tearms and conditions , and agree to use the App